Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 4312

Original article / research
Year : 2017 | Month : November | Volume : 11 | Issue : 11 | Page : DC01 - DC04

Rising Incidence of Non-albicans Candida and Changing Susceptibility Pattern of Bloodstream Candida Isolates in Neonates

Ashish Jain, Sumit Kumar Rawat, Amardeep Rai

1. Assistant Professor, Department of Paeditrics, Bundelkhand Medical College, Sagar, Madhya Pradesh, India. 2. Assistant Professor, Department of Microbiology, Bundelkhand Medical College, Sagar, Madhya Pradesh, India. 3. Professor and Head, Department of Microbiology, Bundelkhand Medical College, Sagar, Madhya Pradesh, India.

Correspondence Address :
Dr. Sumit Kumar Rawat,
House no. 28 Sunrise Town Phase 2 Tilli Roaf Macroniya, Sagar, Madhya Pradesh, India.
E-mail: rawat5000@gmail.com

Abstract

Introduction: Importance of Candida species in nursery and paediatric Intensive Care Units (ICUs) is increasingly being recognized and nowadays isolates resistant to antifungal therapy are on the rise. They account for 9-13% of all bloodstream infection isolates in neonatal intensive care units and also the spectrum of candidemia has changed with the emergence of Non-Albicans Candida (NAC) species, the incidence of which in neonates in different parts of India is not well known.

Aim: To find out the incidence of Non albicans candida among bloodstream infections and to determine susceptibility pattern of Candida blood stream infections in neonates admitted to the NICU of a tertiary care center in a remote part of central India.

Materials and Methods: This study presents prospective cross sectional data on species distribution and changing antifungal susceptibility profiles of 109 Candida bloodstream isolates by automated blood culture by Bact /Alert 3D (Biomerieux) and susceptibility determination by VITEK2 (Biomerieux) automed instrument from all 689 admitted clinically suspected cases of neonatal septicaemia in central India over a 3 year period.

Results: Candida albicans was the Predominant species with 41(37.6%) isolates, followed by Candida parapsilosis 34 (31.1%), Candida tropicalis 18 (16.5%), Candida krusei 11 (10.1%) and Candida glabrata 5 (4.5%). Overall NAC accounted for 68 (62.4%) of all bloodstream Candida infections. The in vitro susceptibility by VITEK2 automated susceptibility testing showed that all C. albicans, C. tropicalis and C. glabrata isolates were susceptible to amphotericin B. Of 34 isolates of C. parapsilosis tested, only 3 (8.8%) and only 2 (18.1%) of C. krusei isolates exhibited an MIC for amphotericin B of >1 µg/ml. Resistance to fluconazole (MIC=32) was observed in all 11 (100%) isolates of C. krusei, 28 (68.3%) of C. albicans isolates, 2 (40%) of C. glabrata and 8 (23.5%) of C parapsilosis isolates. Resistance to 5-flucytosine (MIC =4 µg/ml) was observed in 6 (14.6%) C. albicans isolates, 6 (33.3%) C. tropicalis isolates, 5 (14.7%) C. parapsilosis isolates, 1 (20%) C. glabrata isolate and all 11 (100%) C. krusei isolates. All the isolates of C. albicans, C. tropicalis, C. parapsilosis, were sensitive to voriconazole except only 1 isolate of C. krusei which was also resistant to fluconazole.

Conclusion: In the present study, it was also noted that Candida blood stream infections constitute a large percentage (15.8%) of all neonatal bloodstream infections; our isolation of Candida is higher than some of recent studies. Prevalence of NAC is on rise.

Keywords

Antifungal drugs, Antifungal resistance, Candidemia, Neonatal sepsis, NICU

How to cite this article :

Ashish Jain, Sumit Kumar Rawat, Amardeep Rai. RISING INCIDENCE OF NON-ALBICANS CANDIDA AND CHANGING SUSCEPTIBILITY PATTERN OF BLOODSTREAM CANDIDA ISOLATES IN NEONATES. Journal of Clinical and Diagnostic Research [serial online] 2017 November [cited: 2017 Nov 19 ]; 11:DC01-DC04. Available from
http://jcdr.net/back_issues.asp?issn=0973-709x&year=2017&month=November&volume=11&issue=11&page=DC01-DC04&id=10804

DOI and Others

DOI: 10.7860/JCDR/2017/29492.10804

Date of Submission: Apr 23, 2017
Date of Peer Review: May 13, 2017
Date of Acceptance: Aug 18, 2017
Date of Publishing: Nov 01, 2017

FINANCIAL OR OTHER COMPETING INTERESTS: None.

JCDR is now Monthly and more widely Indexed .
  • PubMed Central® (PMC)New
  • Academic Search Complete Database
  • Chemical Abstracts Service
  • Directory of Open Access Journals (DOAJ)
  • EBSCOhostNew
  • Embase & EMbiology
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Open J-Gate
  • Popline (reproductive health literature)
  • SCOPUS
  • www.omnimedicalsearch.com